← Back to Takeda Pharmaceutical Company Limited
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18952409 | STABILIZED LIQUID AND LYOPHILIZED ADAMTS13 FORMULATIONS | DAVIS, RUTH A | 1699 | §102§112Other | Non-Final OA | — | Pending | Nov 19, 2024 |
| 18908457 | HETEROCYCLIC COMPOUND | RAHMANI, NILOOFAR | 1691 | §112Other | Non-Final OA | — | Pending | Oct 07, 2024 |
| 18852426 | N-(PYRROLIDIN-3-YL OR PIPERIDIN-4-YL)ACETAMIDE DERIVATIVES | REILLY, SOPHIA JANE | 1627 | §103§112 | Non-Final OA | — | Pending | Sep 27, 2024 |
| 18850485 | SOLID FORMS OF TYK2 INHIBITORS AND METHODS OF USE | MARTIN, KEVIN STEPHEN | 1624 | §103§112 | Non-Final OA | — | Pending | Sep 24, 2024 |
| 18829900 | METHODS AND COMPOSITIONS FOR CNS DELIVERY OF ARYLSULFATASE A | ARIANI, KADE | 1651 | §103§112DP | Non-Final OA | — | Pending | Sep 10, 2024 |
| 18678709 | MARIBAVIR COMPOSITIONS AND USES THEREOF | HELM, CARALYNNE E | 1615 | §103§112 | Non-Final OA | — | Pending | May 30, 2024 |
| 18710764 | CELL PRODUCTION METHOD | WILSON, MICHAEL C | 1638 | §102§103§112 | Non-Final OA | — | Pending | May 16, 2024 |
| 18662935 | COMBINATIONS AND METHODS FOR SUBCUTANEOUS ADMINISTRATION OF IMMUNE GLOBULIN AND HYALURONIDASE | ORWIG, KEVIN S | 3991 | §102§103§112DPOther | Non-Final OA | — | Pending | May 13, 2024 |
| 18657004 | PIPERIDINYL-3-(ARYLOXY)PROPANAMIDES AND PROPANOATES | KLINKEL, KORTNEY L | 1627 | §101DP | Non-Final OA | — | Pending | May 07, 2024 |
| 18697196 | METHOD FOR MEASURING CELL CONCENTRATION | TAVERNINI, BREANNA MARIE | 1682 | §103§112 | Non-Final OA | — | Pending | Mar 29, 2024 |
| 18691573 | FACILITATED DELIVERY OF CONCENTRATED ANTIBODY FORMULATIONS USING HYALURONIDASE | HOLLAND, PAUL J | 1656 | §102§112 | Non-Final OA | — | Pending | Mar 13, 2024 |
| 18689723 | INFUSION PUMP | SCHMIDT, EMILY LOUISE | 3783 | §102§112 | Non-Final OA | — | Pending | Mar 06, 2024 |
| 18684541 | SELECTIVE MEASUREMENT OF HUMAN FACTOR VIII | THOMPSON, CURTIS A | 1798 | §102§103§112 | Non-Final OA | — | Pending | Feb 16, 2024 |
| 18292574 | CAR-EXPRESSING IMMUNE CELLS THAT SPECIFICALLY TARGET MESOTHELIN AND USES THEREOF | METCALF, MATTHEW CURRAN | 1647 | §102§103 | Non-Final OA | — | Pending | Jan 26, 2024 |
| 18544966 | EVALUATION, ASSAYS AND TREATMENT OF PKALMEDIATED DISORDERS | SZPERKA, MICHAEL EDWARD | 1641 | §112Other | Final Rejection | — | Pending | Dec 19, 2023 |
| 18539876 | METHOD FOR PRODUCING NATURAL KILLER CELLS FROM PLURIPOTENT STEM CELLS | BELYAVSKYI, MICHAIL A | 1644 | §103DP | Non-Final OA | — | Pending | Dec 14, 2023 |
| 18537204 | RNA BIOMARKERS FOR HEREDITARY ANGIOEDEMA | SITTON, JEHANNE SOUAYA | 1682 | §112 | Final Rejection | 34d | Pending | Dec 12, 2023 |
| 18379047 | VIRAL INHIBITORS, THE SYNTHESIS THEREOF, AND INTERMEDIATES THERETO | LAU, JONATHAN S | 1693 | §103Other | Non-Final OA | 9d | Pending | Oct 11, 2023 |
| 18285714 | THERAPEUTIC METHODS USING CONSTRAINED CONDITIONALLY ACTIVATED BINDING PROTEINS | TAYLOR, LIA ELAN | 1641 | §102§103§112DP | Non-Final OA | — | Pending | Oct 05, 2023 |
| 18553348 | USE OF AN OREXIN 2 RECEPTOR AGONIST FOR POST OPERATION RECOVERY | HOWELL, THEODORE R | 1628 | §103Other | Final Rejection | — | Pending | Sep 29, 2023 |
| 18550474 | IMIDAZOPYRIDINYL INHIBITORS OF PLASMA KALLIKREIN | DEKARSKE, MADELINE MCGUIRE | 1622 | §112Other | Final Rejection | — | Pending | Sep 14, 2023 |
| 18550571 | PLASMA KALLIKREIN INHIBITORS | ROBINSON, MIKHAIL O'DONNEL | 1627 | §112DP | Non-Final OA | 79d overdue | Pending | Sep 14, 2023 |
| 18550504 | INHIBITORS OF PLASMA KALLIKREIN | DEKARSKE, MADELINE MCGUIRE | 1622 | §102§103§112Other | Non-Final OA | — | Pending | Sep 14, 2023 |
| 18550306 | HETEROARYL INHIBITORS OF PLASMA KALLIKREIN | FERGUSON, JALISA HOLMES | 1626 | §112DP | Non-Final OA | — | Pending | Sep 13, 2023 |
| 18546384 | CELL THERAPY COMPOSITIONS AND METHODS FOR MODULATING TGF-B SIGNALING | HOWARD, ZACHARY C | 1674 | §102§112 | Non-Final OA | — | Pending | Aug 14, 2023 |
| 18231982 | FORMULATIONS COMPRISING GLUCOCEREBROSIDASE AND ISOFAGOMINE | CURRENS, GRANT CARSON | 1651 | §103Other | Non-Final OA | — | Pending | Aug 09, 2023 |
| 18361790 | METHODS AND COMPOSITIONS FOR CRYOPRESERVATION OF IMMUNE CELLS | HUMPHRIES, NICHOLAS ADAM | 1631 | §103 | Final Rejection | — | Pending | Jul 28, 2023 |
| 18224308 | METHOD AND APPARATUS FOR PROVIDING A PHARMACOKINETIC DRUG DOSING REGIMEN | FONSECA LOPEZ, FRANCINI ALVARENGA | 1685 | §101§103§112DP | Non-Final OA | — | Pending | Jul 20, 2023 |
| 18266848 | CONDITIONALLY BISPECIFIC BINDING PROTEINS | BUTTICE, AUDREY L | 1647 | §103§112Other | Non-Final OA | 16d | Pending | Jun 13, 2023 |
| 18256565 | COMPOSITIONS OF GUANYLYL CYCLASE C (GCC) ANTIGEN BINDING AGENTS AND METHODS OF USE THEREOF | HADDAD, MAHER M | 1641 | Other | Final Rejection | — | Pending | Jun 08, 2023 |
| 18318218 | CONSTRAINED CONDITIONALLY ACTIVATED BINDING PROTEINS | STOICA, ELLY GERALD | 1647 | §112 | Non-Final OA | — | Pending | May 16, 2023 |
| 18316988 | TREATMENT OF PATIENTS WITH SEVERE VON WILLEBRAND DISEASE UNDERGOING ELECTIVE SURGERY BY ADMINISTRATION OF RECOMBINANT VWF | COFFA, SERGIO | 1658 | §103DP | Non-Final OA | 55d | Pending | May 12, 2023 |
| 18248604 | DETERMINATION OF CELLULAR KINETICS AND BIODISTRIBUTION FOR CAR-T CELLS | SITTON, JEHANNE SOUAYA | 1682 | §101§103§112 | Non-Final OA | — | Pending | Apr 11, 2023 |
| 18025315 | SUBSTITUTED PYRIMIDINE DERIVATIVES AS NICOTINIC ACETYLCHOLINESTERASE RECEPTOR ALPHA 6 MODULATOR | SANCHEZ, JUSTIN CHRISTOPHER | 1622 | §112 | Non-Final OA | 76d | Pending | Mar 08, 2023 |
| 17916441 | ADAMTS13 VARIANT, COMPOSITIONS, AND USES THEREOF | ROBINSON, HOPE A | 1652 | §112 | Non-Final OA | 72d overdue | Pending | Sep 30, 2022 |
| 17906433 | IMPLANTABLE CELL CHAMBER DEVICE AND USES THEREOF | BECKHARDT, LYNDSEY MARIE | 1613 | §103 | Final Rejection | 16d overdue | Pending | Sep 15, 2022 |
| 17759992 | TREATMENT OF MENORRHAGIA IN PATIENTS WITH SEVERE VON WILLEBRAND DISEASE BY ADMINISTRATION OF RECOMBINANT VWF | BARSKY, JARED | 1628 | §103§112 | Non-Final OA | — | Pending | Aug 02, 2022 |
| 17773467 | METHOD FOR PRODUCING T CELLS | ABBOTT, KODYE LEE | 1634 | §112 | Non-Final OA | — | Pending | Apr 29, 2022 |
| 17769452 | METHOD FOR EVALUATING DRUG TOXICITY | MARTIN, RACHEL E | 1657 | §101§103§112 | Non-Final OA | 127d overdue | Pending | Apr 15, 2022 |
| 17622580 | TRANSFECTION METHOD | MEJIAS, SAMANTHA LEE | 1618 | §103DP | Non-Final OA | 15d | Pending | Dec 23, 2021 |
| 17556857 | PURIFICATION OF FVIII FROM PLASMA USING SILICON OXIDE ADSORPTION | ESPINOSA, CLAUDIA EDILMA | 1654 | §102§103§112 | Final Rejection | 66d overdue | Pending | Dec 20, 2021 |
| 17491813 | EVALUATION AND TREATMENT OF BRADYKININ-MEDIATED DISORDERS | PETRASH, HILARY ANN | 1644 | §112 | Final Rejection | 8d | Pending | Oct 01, 2021 |
| 17362191 | METHODS OF PROPHYLACTIC TREATMENT USING RECOMBINANT VWF (rVWF) | AUDET, MAURY A | 1654 | §103 | Non-Final OA | 79d | Pending | Jun 29, 2021 |
| 17416859 | T-CELL RECEPTOR MODIFIED OBJECT | GEORGE, DENNIS CHERIAN | 1644 | §103DP | Final Rejection | — | Pending | Jun 21, 2021 |
| 17326884 | RECOMBINANT VIRAL VECTORS AND NUCLEIC ACIDS FOR PRODUCING THE SAME | JOHNSON, ALLISON MARIE | 1638 | §103 | Final Rejection | — | Pending | May 21, 2021 |
| 17279228 | GIP RECEPTOR AGONIST PEPTIDE COMPOUNDS AND USES THEREOF | D' AMBROSIO, THEA | 1654 | §103§112DP | Final Rejection | — | Pending | Mar 24, 2021 |
| 17263675 | METHOD FOR PRODUCING CD3-POSITIVE CELL | SHUPE, ELIZABETH A | 1643 | §103 | Final Rejection | 19d | Pending | Jan 27, 2021 |
| 16817671 | PLASMA KALLIKREIN INHIBITORS AND USES THEREOF FOR TREATING HEREDITARY ANGIOEDEMA ATTACK | KIM, YUNSOO | 1641 | §112Other | Final Rejection | — | Pending | Mar 13, 2020 |
| 16208294 | FORMULATION FOR ANTI-ALPHA4BETA7 ANTIBODY AND METHODS OF TREATMENT | HADDAD, MAHER M | 1641 | DP | Non-Final OA | — | Pending | Dec 03, 2018 |
| 14437902 | METHOD FOR PREPARATION OF A HIGH CONCENTRATION LIQUID FORMULATION OF AN ANTIBODY | JUEDES, AMY E | 1644 | §103DP | Final Rejection | — | Pending | Apr 23, 2015 |
| 18835922 | ZIKA VACCINES AND IMMUNOGENIC COMPOSITIONS, AND METHODS OF USING THE SAME | ZOU, NIANXIANG | 1671 | §102§103§112 | Non-Final OA | — | Pending | Aug 05, 2024 |
| 18687763 | IMMUNOFOCUS ASSAY FOR DETERMINING THE TITER OF DENGUE VIRUSES | BOESEN, AGNIESZKA | 1672 | §103 | Non-Final OA | — | Pending | Feb 28, 2024 |
| 18030647 | METHODS FOR DETERMINING COMPLEMENT-FIXING ANTIBODIES | ZOU, NIANXIANG | 1671 | §103 | Final Rejection | — | Pending | Apr 06, 2023 |
| 17416810 | NOROVIRUS VACCINE FORMULATIONS AND METHODS | SIFFORD, JEFFREY MARK | 1671 | §103§112Other | Final Rejection | 46d overdue | Pending | Jun 21, 2021 |
| 17274016 | DENGUE VACCINE UNIT DOSE AND ADMINISTRATION THEREOF | SIFFORD, JEFFREY MARK | 1671 | §103Other | Non-Final OA | 87d overdue | Pending | Mar 05, 2021 |
